Literature DB >> 1677097

Pulsed high-dose cefotaxime therapy in refractory Lyme borreliosis.

D Hassler, K Riedel, J Zorn, V Preac-Mursic.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1991        PMID： 1677097     DOI： 10.1016/0140-6736(91)90188-u

Source DB:  PubMed          Journal:  Lancet        ISSN： 0140-6736            Impact factor:   79.321


× No keyword cloud information.
  5 in total

1.  A proposal for the reliable culture of Borrelia burgdorferi from patients with chronic Lyme disease, even from those previously aggressively treated.

Authors:  S E Phillips; L H Mattman; D Hulínská; H Moayad
Journal:  Infection       Date:  1998 Nov-Dec       Impact factor: 3.553

2.  Long-term results in patients with Lyme arthritis following treatment with ceftriaxone.

Authors:  H Valesová; J Mailer; J Havlík; D Hulínská; J Hercogová
Journal:  Infection       Date:  1996 Jan-Feb       Impact factor: 3.553

Review 3.  Treatment of Lyme arthritis.

Authors:  M A Cimmino; G L Moggiana; M Parisi; S Accardo
Journal:  Infection       Date:  1996 Jan-Feb       Impact factor: 3.553

4.  Persistence of Borrelia burgdorferi in experimentally infected dogs after antibiotic treatment.

Authors:  R K Straubinger; B A Summers; Y F Chang; M J Appel
Journal:  J Clin Microbiol       Date:  1997-01       Impact factor: 5.948

5.  Lyme disease: the sensible pursuit of answers.

Authors:  K B Liegner
Journal:  J Clin Microbiol       Date:  1993-08       Impact factor: 5.948
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.